Zymeworks Inc.

US$29.63As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ZYMEHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 9.03%
Div yield —
ROE (72.31%)
Biotechnology
Beta (5Y) 1.30
PE TTM —
TSR TTM 55.25%
Mkt cap US$2.103B
ROIC (97.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$29
(1.95%)
(92.68%)
Hold 6|1|2|4|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.45
0.43
0.45
0.48
5.98%
0.69%
1.56%
1.62%
Revenue$M
158.0
155.7
164.1
166.1
7.13%
1.18%
5.47%
9.86%
Peers (US$2.103B)
Cap (US$)
PE
2.112B
90.48x
Capital
TTM
5Y
10Y
Leveragex
0.616
0.034
0.025
EBIT/Intx
13.45
0.044
0.053
Own earn%
43.09
(30.30)
(30.69)
Sh yield%
35.00
23.69
26.51
Owners
Insiders/Inst%
10.25
67.28
Short interest%
3.13
SBC / revenue%
3.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
2–8
$1 testx
0.0
Incr. ROIC%
0